Transforming The World of the RYR-1 Community
The RYR-1 Foundation exists to raise funds that support both basic science and clinical research of RYR-1-related diseases. Funding research gives us the best chance to find a treatment or a cure.
As of 2022, The RYR-1 Foundation has funded/committed over $1.7 million in RYR-1-related research. This has already led to important advances in knowledge and potential therapies.
In 2016, the RYR-1 Foundation awarded a grant of $80,000 to Dr. Andrew Marks, Chairman of the Department of Physiology and Cellular Biophysics at Columbia University, and Dr. Katherine Meilleur, former Assistant Clinical Investigator at the National Institute of Nursing Research, for their research project entitled “Rycal Treatment in RYR-1-Related Myopathy Muscle Biopsies.”